1 results match your criteria: "National Institute for Biotechnology and Genetic Engineering Faisalabad Pakistan.[Affiliation]"
Article Synopsis
- The COVID-19 pandemic has posed significant challenges to global healthcare, prompting a search for better treatment options alongside existing FDA-approved therapies.
- The clinical management of COVID-19 involves infection prevention and supportive care, such as oxygen therapy and mechanical ventilation, while emergency protocols have been established to expedite patient access to potential treatments.
- This manuscript explores the potential of using short-interfering RNA (siRNA) for targeting and degrading the SARS-CoV-2 genome, highlighting delivery methods using FDA-approved nanoparticulate systems that could be formulated as inhalable aerosols.